Seers Technology (458870.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea
Seers Technology financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 8.10 bn KRW | 48.17 bn KRW |
| Gross profit | 3.44 bn KRW | 34.88 bn KRW |
| Operating income | -8.68 bn KRW | 16.33 bn KRW |
| EBIT | -8.39 bn KRW | 16.34 bn KRW |
| Net income | -8.87 bn KRW | 16.09 bn KRW |
| Diluted EPS – continuing operations | -706.79 KRW | 423.42 KRW |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Seers Technology
SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea. It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material. The company was formerly known as Seers Technology Co., LTD. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.
More stocks
- LX Holdings Corp. Pfd. (38380K.KS)
- APAQ Technology Co Ltd (6449.TW)
- Xin Hee Co Ltd (003016.SZ)
- Ronshin Group A (301231.SZ)
- Korea SPAC 3 (222080.KQ)
- Chang Lan Electric Technology Co Ltd (002879.SZ)
- Citra Putra Realty Tbk PT (CLAY.JK)
- Cham Swiss Properties AG (CHAM.SW)
- BrightSpire Capital, Inc. (BRSP)
- Changzhou Evergreen Technology Co. Ltd. A (001324.SZ)
- Onconic Therapeutics Inc. (476060.KQ)
- IQE PLC (IQE.L)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.